A population-based study of IL4 polymorphisms in multiple sclerosis

Journal of Neuroimmunology

Volumn 137, Issue 1-2, 2003, Pages 134-139

  Kantarci, Orhun H ^a   Schaefer Klein, Janet L ^a   Hebrink, David D ^a   Achenbach, Sara J ^a   Atkinson, Elizabeth J ^a   McMurray, Cynthia T ^a   Weinshenker, Brian G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Interleukin 4; Multiple sclerosis; Polymorphism; Prognosis; Severity; Susceptibility

Indexed keywords

INTERLEUKIN 4;

ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CARRIER; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; ONSET AGE; PATIENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; RNA SPLICING;

EID: 0037376325     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00046-8     Document Type: Article

References (26)

1. Aithal G.P., Day C.P., Leathart J., Daly A.K., Hudson M. Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population. Genes Immun. 2(1):2001;44-47.
2. Constantinescu C.S., Hilliard B., Ventura E., Wysocka M., Showe L., Lavi E., Fujioka T., Scott P., Trinchieri G., Rostami A. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively. Clin. Immunol. 98(1):2001;23-30.
3. Elliott K., Fitzpatrick E., Hill D., Brown J., Adams S., Chee P., Stewart G., Fulcher D., Tang M., Kemp A., King E., Varigos G., Bahlo M., Forrest D.P. The -590C/T and -34C/T interleukin-4 promoter polymorphisms are not associated with atopic eczema in childhood. J. Allergy Clin. Immunol. 108(2):2001;285-287.
4. Falcone M., Rajan A.J., Bloom B.R., Brosnan C.F. A critical role of IL-4 in regulating disease severity in experimental autoimmune encephalomyelitis as demonstrated in IL-4 deficient C57BL/6 mice and BALB/c mice. J. Immunol. 160:1998;4822-4830.
5. He B., Xu C., Yang B., Landtblom A.M., Fredrikson S., Hillert J. Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis. J. Neuroimmunol. 86:1998;13-19.
6. Heward J.M., Nithiyananthan A., Allahabadia S., Gibson S., Franklyn J.A., Gough S.C.L. No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom. J. Clin. Endocrinol. Metab. 86(8):2001;3861-3863.
7. Hunt P.J., Marshall S.E., Weetman A.P., Bell J.I., Wass J.A., Welsh K.I. Cytokine gene polymorphisms in autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 85(5):2000;1984-1988.
8. Kantarci O., Siva A., Eraksoy M., Karabudak R., Sutlas N., Agaoglu J., Turan F., Ozmenoglu M., Togrul E., Demirkiran M. Survival and predictors of disability in Turkish MS patients. Neurology. 51(3):1998;765-772.
9. Kantarci O.H., Atkinson E.J., Hebrink D.D., McMurray C.T., Weinshenker B.G. Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis. J. Neuroimmunol. 106(1-2):2000;220-227.
10. Kipp B., Bar-Or A., Gausling R., Oliveira E.M., Fruhan S.A., Stuart W.H., Hafler D.A. A novel population of B7-1+T cells producing intracellular IL-4 is decreased in patients with multiple sclerosis. Eur. J. Immunol. 30(7):2000;2092-2100.
11. Klein W., Tromm A., Griga T., Fricke H., Folwaczny C., Hocke M., Eitner K., Marx M., Duerig N., Epplen J.T. Interleukin-4 and interleukin-4 receptor polymorphisms in inflammatory bowel diseases. Genes Immun. 2(5):2001;287-289.
12. Liu Q., Sommer S. Parameters affecting the sensitivities of dideoxyfingerprinting and SSCP. PCR Methods Appl. 4:1994;97-108.
13. Martino G., Poliani P.L., Furlan R., Marconi P., Glorioso J.C., Adorini L., Comi G. Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach. J. Neuroimmunol. 107(2):2000;184-190.
14. McDonnell G.V., Kirk C.W., Hawkins S.A., Graham C.A. An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis. J. Neurol. Sci. 176:2000;4-12.
15. Michel J., Gonzales J.R., Wunderlich D., Diete A., Herrmann J.M., Meyle J. Interleukin-4 polymorphisms in early onset periodontitis. J. Clin. Periodontol. 28:2001;483-488.
16. Navikas V., Link H. Review: cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:1996;322-333.
17. Panitch H.S., Hirsch R.L., Haley A.S., Johnson K.P. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet. 1(8538):1987;893-895.
18. Peleman R., Wu I., Fargeas C., Delespesse G. Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells. J. Exp. Med. 170:1989;1751-1756.
19. Rodriguez M., Siva A., Ward J., Stolp-Smith K., O'Brien P., Kurland L. Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota. Neurology. 44:1994;78-83.
20. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 70:2002;425-434.
21. Sommer S.S., Groszbach A.R., Bottema C.D. PCR amplification of specific alleles is a general method for rapidly detecting known single base changes. BioTechniques. 12:1992;82-87.
22. Street N.E., Mosmann T.R. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5:1991;171-177.
23. Vandenbroeck K., Martino G., Marrosu M.G., Consiglio A., Zaffaroni M., Vaccargiu S., Franciotta D., Ruggeri M., Comi G., Grimaldi L.M.E. Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. J. Neuroimmunol. 76:1997;189-192.
24. Wallney A.J., Cokkson W.O.C.M. Investigation of an interleukin-4 promoter polymorphism for association with asthma and atopy. J. Med. Genet. 33:1996;689-692.
25. Weinshenker B.G. The natural history of multiple sclerosis. Neurol. Clin. 1:1995;119-146.
26. Weinshenker B.G., Wingerchuk D.M., Liu Q., Bissonet A.S., Schaid D.J., Sommer S.S. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology. 49(2):1997;378-385.